Daptomycin for Children in Clinical Practice Experience

Silvia Garazzino; Elio Castagnola; Maria Di Gangi; Rita Ortolano; Andrzej Krzysztofiak; Agostino Nocerino; Susanna Esposito; Patrizia D'Argenio; Luisa Galli; Giuseppe Losurdo; Carmelina Calitri; P. A. Tovo; Roberto Bandettini; Salvatore Giordano; Piera Dones; Ottavio Ziino; Clara Mosa; Margherita Robazza; Claudia Tagliabue; Laura Lancella; Francesca Carraro

doi:10.1097/INF.0000000000001121

Daptomycin for Children in Clinical Practice Experience

Silvia Garazzino, Elio Castagnola, Maria Di Gangi, Rita Ortolano, Andrzej Krzysztofiak, Agostino Nocerino, Susanna Esposito, Patrizia D'Argenio, Luisa Galli, Giuseppe Losurdo, Carmelina Calitri, P. A. Tovo, Roberto Bandettini, Salvatore Giordano, Piera Dones, Ottavio Ziino, Clara Mosa, Margherita Robazza, Claudia Tagliabue, Laura LancellaFrancesca Carraro

Research output: Contribution to journal › Article › peer-review

Abstract

Data on daptomycin use in the pediatric setting are scanty. We conducted a multicenter, retrospective study on 46 children treated with intravenous daptomycin at a mean dosage of 7.0 mg/kg/day and for a median of 14 days. Three children had adverse events possibly related to daptomycin. The drug was overall well tolerated, even with prolonged treatment.

Original language	English
Pages (from-to)	639-641
Number of pages	3
Journal	Pediatric Infectious Disease Journal
Volume	35
Issue number	6
DOIs	https://doi.org/10.1097/INF.0000000000001121
Publication status	Published - 2016

ASJC Scopus subject areas

Pediatrics, Perinatology, and Child Health
Infectious Diseases
Microbiology (medical)

Access to Document

10.1097/INF.0000000000001121

Fingerprint Dive into the research topics of 'Daptomycin for Children in Clinical Practice Experience'. Together they form a unique fingerprint.

Cite this

Garazzino, S., Castagnola, E., Di Gangi, M., Ortolano, R., Krzysztofiak, A., Nocerino, A., Esposito, S., D'Argenio, P., Galli, L., Losurdo, G., Calitri, C., Tovo, P. A., Bandettini, R., Giordano, S., Dones, P., Ziino, O., Mosa, C., Robazza, M., Tagliabue, C., ... Carraro, F. (2016). Daptomycin for Children in Clinical Practice Experience. Pediatric Infectious Disease Journal, 35(6), 639-641. https://doi.org/10.1097/INF.0000000000001121

Daptomycin for Children in Clinical Practice Experience. / Garazzino, Silvia; Castagnola, Elio; Di Gangi, Maria; Ortolano, Rita; Krzysztofiak, Andrzej; Nocerino, Agostino; Esposito, Susanna; D'Argenio, Patrizia; Galli, Luisa; Losurdo, Giuseppe; Calitri, Carmelina; Tovo, P. A.; Bandettini, Roberto; Giordano, Salvatore; Dones, Piera; Ziino, Ottavio; Mosa, Clara; Robazza, Margherita; Tagliabue, Claudia ; Lancella, Laura; Carraro, Francesca.

In: Pediatric Infectious Disease Journal, Vol. 35, No. 6, 2016, p. 639-641.

Research output: Contribution to journal › Article › peer-review

Garazzino, S, Castagnola, E, Di Gangi, M, Ortolano, R, Krzysztofiak, A, Nocerino, A, Esposito, S, D'Argenio, P, Galli, L, Losurdo, G, Calitri, C, Tovo, PA, Bandettini, R, Giordano, S, Dones, P, Ziino, O, Mosa, C, Robazza, M, Tagliabue, C , Lancella, L & Carraro, F 2016, 'Daptomycin for Children in Clinical Practice Experience', Pediatric Infectious Disease Journal, vol. 35, no. 6, pp. 639-641. https://doi.org/10.1097/INF.0000000000001121

Garazzino, Silvia ; Castagnola, Elio ; Di Gangi, Maria ; Ortolano, Rita ; Krzysztofiak, Andrzej ; Nocerino, Agostino ; Esposito, Susanna ; D'Argenio, Patrizia ; Galli, Luisa ; Losurdo, Giuseppe ; Calitri, Carmelina ; Tovo, P. A. ; Bandettini, Roberto ; Giordano, Salvatore ; Dones, Piera ; Ziino, Ottavio ; Mosa, Clara ; Robazza, Margherita ; Tagliabue, Claudia ; Lancella, Laura ; Carraro, Francesca. / Daptomycin for Children in Clinical Practice Experience. In: Pediatric Infectious Disease Journal. 2016 ; Vol. 35, No. 6. pp. 639-641.

@article{e565aa56bcff4c449e8ec81c57a0a830,

title = "Daptomycin for Children in Clinical Practice Experience",

abstract = "Data on daptomycin use in the pediatric setting are scanty. We conducted a multicenter, retrospective study on 46 children treated with intravenous daptomycin at a mean dosage of 7.0 mg/kg/day and for a median of 14 days. Three children had adverse events possibly related to daptomycin. The drug was overall well tolerated, even with prolonged treatment.",

author = "Silvia Garazzino and Elio Castagnola and {Di Gangi}, Maria and Rita Ortolano and Andrzej Krzysztofiak and Agostino Nocerino and Susanna Esposito and Patrizia D'Argenio and Luisa Galli and Giuseppe Losurdo and Carmelina Calitri and Tovo, {P. A.} and Roberto Bandettini and Salvatore Giordano and Piera Dones and Ottavio Ziino and Clara Mosa and Margherita Robazza and Claudia Tagliabue and Laura Lancella and Francesca Carraro",

year = "2016",

doi = "10.1097/INF.0000000000001121",

language = "English",

volume = "35",

pages = "639--641",

journal = "Pediatric Infectious Disease Journal",

issn = "0891-3668",

publisher = "Lippincott Williams and Wilkins",

number = "6",

}

TY - JOUR

T1 - Daptomycin for Children in Clinical Practice Experience

AU - Garazzino, Silvia

AU - Castagnola, Elio

AU - Di Gangi, Maria

AU - Ortolano, Rita

AU - Krzysztofiak, Andrzej

AU - Nocerino, Agostino

AU - Esposito, Susanna

AU - D'Argenio, Patrizia

AU - Galli, Luisa

AU - Losurdo, Giuseppe

AU - Calitri, Carmelina

AU - Tovo, P. A.

AU - Bandettini, Roberto

AU - Giordano, Salvatore

AU - Dones, Piera

AU - Ziino, Ottavio

AU - Mosa, Clara

AU - Robazza, Margherita

AU - Tagliabue, Claudia

AU - Lancella, Laura

AU - Carraro, Francesca

PY - 2016

Y1 - 2016

N2 - Data on daptomycin use in the pediatric setting are scanty. We conducted a multicenter, retrospective study on 46 children treated with intravenous daptomycin at a mean dosage of 7.0 mg/kg/day and for a median of 14 days. Three children had adverse events possibly related to daptomycin. The drug was overall well tolerated, even with prolonged treatment.

AB - Data on daptomycin use in the pediatric setting are scanty. We conducted a multicenter, retrospective study on 46 children treated with intravenous daptomycin at a mean dosage of 7.0 mg/kg/day and for a median of 14 days. Three children had adverse events possibly related to daptomycin. The drug was overall well tolerated, even with prolonged treatment.

UR - http://www.scopus.com/inward/record.url?scp=84959091964&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84959091964&partnerID=8YFLogxK

U2 - 10.1097/INF.0000000000001121

DO - 10.1097/INF.0000000000001121

M3 - Article

VL - 35

SP - 639

EP - 641

JO - Pediatric Infectious Disease Journal

JF - Pediatric Infectious Disease Journal

SN - 0891-3668

IS - 6

ER -

Daptomycin for Children in Clinical Practice Experience

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this